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Abstract
I In nt tr ro od du uc ct ti io on n: :   To evaluate clinical value of a new self-sequential longitudinal
reference intervals of thyroid function during pregnancy. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   We established two different series of reference intervals:
self-sequential longitudinal reference intervals (SLRI) and general gestation-
specific reference intervals (GSRI). For SLRI, the serum of 301 cases were collected
five times in every case throughout the gestation. For GSRI, A total of 1455 subjects
included in the study. We collected the serum respectively at various trimesters.
We used TSH of both reference intervals to screen 1744 pregnant women, and
compared the percentage of potential misclassification. 
R Re es su ul lt ts s: :   Both SLRI and GSRI differed substantially from that for non-pregnant
women (p < 0.05). There are similar fluctuations of serum TSH, FT4 and 
TPO-Ab during normal pregnancy. Although there were no significant differences
in most reference intervals between SLRI and GSRI. But the IQR of SLRI were
usually smaller than GSRI , especially in 1st trimester. Two hundred and fifty two
women (14.4%) at various trimesters whose serum TSH concentration was within
SLRI would be misclassified, while 23 women (1.3%) with a TSH concentration
outside limit would not be identified. 0.11-3.84% women would got thyroid
diseases during pregnancy. Subclinical hypothyroidism is most common maternal
thyroid disorders.
C Co on nc cl lu us si io on ns s: :   The SLRI can reflected the changes of thyroid function realistically,
and can be used to decrease the percentage of potential misclassification of
thyroid dysfunction during pregnancy. Screening for thyroid dysfunction of
pregnant women is recommended and important.
K Ke ey y   w wo or rd ds s: :   pregnancy, thyroid hormones, reference intervals, self-sequential,
outcome.
Introduction
It is well known that it is very important to evaluate thyroid function
accurately during pregnancy [1-3]. Maternal thyroid dysfunction or only
the presence of thyroid-specific antibodies is associated with increased
risk for early abortion, preterm delivery, neonatal morbidity [1, 4] and
some obstetrical complications [5, 6], such as premature delivery,
gestational hypertension, pre-eclampsia, and placental abruption.
Benhadi  et  al. have  reported  that  higher  maternal  TSH  levels  in
pregnancy would increase miscarriage by 60% [7]. Männistö et al. found
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :   
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that  women  with  thyroid  dysfunction  and
antibodies during pregnancy were more prone to
get thyroid disease later [8]. Maternal thyroid
function is important not only to the parent 
but also to the fetus. For example, maternal
hypothyroidism, even very mild, can have adverse
effects  on  cognitive  and  neurological  deve  -
lopment of the fetus [2]. Both mild and severe
maternal hypothyroxinaemia are a higher risk
factor for cognitive delay in early childhood [9].
So recently researchers of perinatal medicine
reached an agreement that screening thyroid
dysfunction of pregnant women is recommended
and important.
During a normal pregnancy, great physiological
changes in the mother induce complex endocrine
and immune responses. At the same time, thyroid
gland  volume  may  increase,  the  thyroid  is
hyperstimulated, and thyroid hormone concen  -
trations change [10-13]. Recently, researchers
recommended  the  use  of  gestation-specific
reference intervals to evaluate maternal thyroid
function. If a non-pregnant reference range is
used, many maternal thyroid diseases could be
potentially misclassified [14-16]. Some researchers
have attempted to establish the gestation-specific
reference intervals for a local population, such as
Malaysian [16], Chinese [17, 18], Spanish [19],
Indian [20], Australian [21], English [22], Czech
[23], and so on. However, most studies are based
on cross-sectional studies from different women
in different stages of gestation. In our last study,
we established new self-sequential longitudinal
reference intervals based on the same group of
pregnant women [24]. The new ranges could
reflect the changes of thyroid function in pregnant
women more realistically and reduce the variation
caused by sampling error from different groups.
Maybe it can also give a more accurate value for
clinical diagnosis and therapy.
The aim of this study was to evaluate the
clinical value of the self-sequential longitudinal
reference intervals of thyroid function during
pregnancy. First, we established two different
series of reference intervals for serum thyroid
stimulating hormone (TSH), free thyroxine (FT4)
and thyroid peroxidase antibodies (TPO-Ab) during
pregnancy: self-sequential longitudinal reference
intervals (SLRI) and general gestation-specific
reference intervals (GSRI). Then we used both
reference intervals to clinically evaluate the status
of  thyroid  function  of  pregnant  women, 
and  observed  the  percentage  of  potential
misclassification  and  the  relationship  with
pregnancy  outcome.  So  we  can  know  the
advantage of the self-sequential longitudinal
reference intervals for the diagnosis of thyroid
dysfunction during pregnancy.
Material and methods
S St tu ud dy y   d de es si ig gn n
This study was designed and undertaken in the
Changzhou Women and Children Health Hospital
of Nanjing Medical University, Jiangsu Province,
China.  The  cases  of  this  study  comprised  the
pregnant women who regularly checked in to our
hospital for early pregnancy prenatal care from June
2008 to December 2009. 
T Ta ar rg ge et t   p po op pu ul la at ti io on n   a an nd d   i in nc cl lu us si io on n   c cr ri it te er ri ia a
Based  on  the  research  of  Teng  [25],  we
established selection criteria as follows: 1) no past
history of thyroid disease, 2) no life history in the
areas of endemic goitre, 3) no other history of
autoimmune  diseases,  4)  no  medical  history
affecting thyroid function, 5) normal urinary iodine,
6) singleton pregnancies, 7) TPO-Ab negative (< 5.0
IU/ml),  8)  after  follow-up,  no  hyperemesis
gravidarum,  pregnancy-induced  hypertension,
gestational diabetes, premature birth or other
adverse maternal-fetal outcomes.
For SLRI, 301 cases were included in the study
[24]. For GSRI, a total of 1455 subjects were included
in the study: 406 in the 1st trimester, 388 in the 2nd
trimester, and 661 in the 3rd trimester were selected
to establish general gestation-specific reference
intervals. Their age was 26.21 ±6.35 years and the
height was 157.4 ±11.2 cm.
S Sa am mp pl le es s   c co ol ll le ec ct ti io on n
For SLRI, samples of every case were collected
five times throughout the gestation [24]. For GSRI,
we collected the sera respectively from 1455 women
at various trimesters of pregnancy. Three ml of
blood of all the cases were collected by simple
needle aspiration. The samples were centrifuged at
3000 rpm for 5 min to remove cells. The serum was
stored at –86°C until assays.
T Te es st t
The levels of TSH, FT4 and TPO-Ab were quanti  -
fied by electrochemistry immunoassay (ECL) using
a COBAS  e601  automated  analyser  (Roche
Diagnostics, Germany). We observed the dynamic
change of thyroid hormone over all gestation. Then
we established two reference intervals. All cases
were followed by a survey of hospital medical
record and telephone interview. The detection range
of serum TSH is 0.005-100 mIU/l, and 0.3-100
pmol/l for FT4, 5-600 IU/ml for TPO-Ab.
C Cl li in ni ic ca al l   e ev va al lu ua at ti io on n
In the study, we explored initially the value of
clinical  evaluation  and  diagnosis.  Serum  TSHArch Med Sci 4, August / 2011 681
provides the most sensitive index to reliably detect
thyroid function abnormalities [26]. At first, we used
TSH  of  both  reference  intervals  to  screen 
1744 pregnant women (458 in the 1st trimester, 
449  in  the  2nd trimester,  and  837  in  the  3rd
trimester),  and  compared  the  percentage  of
potential  misclassification.  According  to  their
gestational weeks, we selected the best reference
intervals  as  the  standard  of  diagnosis.  After
following up all cases, we observed the occurrences
of pregnancy complication, including pre-eclampsia,
hypertensive disorder complicating pregnancy,
gestational diabetes mellitus, premature birth,
intrahepatic cholestasis of pregnancy, and so on.
Then,  we  analysed  the  relationship  between
misclassification and pregnancy outcome.
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
All data were collected and statistically analysed
by SPSS 13.0 software. Results of parameters were
expressed as median (M), interquartile range (IQR),
2.5th percentile (P2.5) and 97.5th percentile (P97.5).
The limits of the reference intervals were calculated
as  P2.5  to  P97.5.  Non-parametric  tests  were
employed  to  compare  differences  in  thyroid
hormones (the median level); comparisons among
groups  with  different  gestational  ages  were
performed with Kruskal-Wallis test (H test) and
comparisons between two different groups were
compared with Wilcoxon test. Mann-Whitney U test
was used to compare the difference between SLRI
and GSRI. Positive ratios were calculated by χ2-test.
A value of p of less than 0.05 was considered to be
statistically significant.
Details of ethics approval
The study design and protocol were reviewed
and  approved  by  the  ethics  committee  of
Changzhou Women and Children Health Hospital
affiliated to Nanjing Medical University.
Results
Table I shows the median, P2.5-P97.5, IQR of
serum TSH, FT4 and TPO-Ab. There are similar
fluctuations of serum TSH, FT4 and TPO-Ab in SLRI
and GSRI during normal pregnancy. 
Compared with normal non-pregnant women,
serum  TSH  was  at  a low  level  during  the  1st
trimester (p < 0.05), and began to rise, but always
at a lower level (p < 0.05) (Figure 1). The level of FT4
was consistently lower than the non-pregnant
group (p < 0.05), and tended to a steady state
(Figure  2).  TPO-Ab  rose  continuously  all  over
gestation. It was significantly higher in the 3rd
trimester (p < 0.05) (Figure 3). There were no
significant differences in most reference intervals
between SLRI and GSRI. But the IQR of SLRI was
usually smaller than GSRI, especially in the 1st
trimester. 
Based on the results of 1744 pregnant women,
SLRI had the best clinical specificity among three
reference intervals in the 1st trimester and 2nd
trimester. Women whose TSH level was outside
SLRI  would  have  higher  risk  of  pregnancy
complications (p < 0.01). The difference of risk was
greatest in the 2nd trimester (34.6% vs. 9.5%, 
p < 0.001). For GSRI, it was also satisfied results in
the 2nd trimester and 3rd trimester (p < 0.05).
However, there were no significant differences in
non-pregnant reference interval throughout the
gestation (p > 0.05).
In  order  to  evaluate  the  value  of  clinical
diagnosis, we investigated the thyroid function of
1744 pregnant women with SLRI. The number and
percentage of potentially misclassification if non-
pregnant  reference  intervals  were  used  are
summarized in Table II. Two hundred and fifty-two
women (14.4%) at various trimesters whose serum
TSH  concentration  was  within  SLRI  would  be
misclassified, while 23 women (1.3%) with a TSH
concentration  outside  the  limit  would  not  be
G Ge es st ta at ti io on n G Gr ro ou up p n n T TS SH H   [ [m ml lU U/ /l l] ] F FT T4 4   [ [p pm mo ol l/ /l l] ] T TP PO OA Ab b   [ [I IU U/ /m ml l] ]
M M( (P P2 2. .5 5- -P P9 97 7. .5 5) ) I IQ QR R M M( (P P2 2. .5 5- -P P9 97 7. .5 5) ) I IQ QR R M M( (P P2 2. .5 5- -P P9 97 7. .5 5) ) I IQ QR R
1st SLRI[24] 301 1.00 (0.02-3.65)# 1.18 15.48 (11.85-21.51)# 3.05 6.35 (5.00-19.69)* 4.03
trimester
GSRI 406 1.08 (0.19-3.54)# 1.26 16.04 (12.01-24.62)# 3.06 8.63 (5.00-20.45)# 6.83
2nd SLRI[24] 301 1.26 (0.36-3.46)# 0.93 12.08 (9.45-16.26)*# 2.12 7.05 (5.00-19.92)* 5.13
trimester
GSRI 388 1.35 (0.38-3.29)# 0.94 12.64 (9.53-16.91)# 2.46 9.57 (5.00-31.05)# 8.38
3rd SLRI[24] 301 1.50 (0.44-5.04)*# 1.10 12.62 (9.30-17.14)# 2.59 8.63 (5.00-21.96)*# 4.97
trimester
GSRI 661 1.72 (0.51-5.43)# 1.36 12.86 (9.37-17.14)# 2.52 9.71 (5.00-25.68)# 6.95
Non-preg- 150 2.10 (0.75-5.28) 1.35 17.71 (14.35-21.69) 2.22 6.78 (5.00-22.42) 2.92
nancy[24]
*Compared with GSRI group, p < 0.05, #Compared with non-pregnancy group, p < 0.05
T Ta ab bl le e   I I. .   Reference intervals of thyroid function in normal pregnant women
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identified. The potential for misclassification of TSH
results was greatest in the 1st trimester (31.0%).
During  the  later  pregnancy,  34.8%  of  missed
diagnosis cases would have had some pregnancy
complications. However, only 9.1% of the misdia  -
gnoses  might  have  occurred.  If  the  GSRI  was
applied, a total of 40 women (2.3%) would have
been incorrectly classified, and only 3 women (0.1%)
would not have been identified. Both SLRI and GSRI
were quite consistent in clinical diagnosis. 
Table  III  shows  the  prevalence  of  thyroid
hormone during pregnancy clinically evaluated with
SLRI. 0.11-3.84% of women would have got thyroid
diseases during pregnancy, including hypothy  -
roidism, subclinical hypothyroidism, and hyper  -
thyroxinaemia. Subclinical hypothyroidism is the
most  common  maternal  thyroid  disorder.  The
positive rate of TPO-Ab was 8.66% throughout 
the gestation.
Discussion
The basic premise for clinical management of
thyroid disease in pregnancy is in accurate laboratory
measurement of thyroid hormones. Because of
complicated physiological changes during pregnancy,
it is urged to establish the normal gestational-specific
reference values of thyroid function. Recently, several
studies  have  already  established  the  normal
gestational-specific reference intervals of thyroid
function [16-23]. However, most of the present
reference ranges were based on the cross-sectional
survey from different populations. Andersen et al.
[27] have reported that the intra-individual variation
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G Ge es st ta at ti io on n N N M Mi is sd di ia ag gn no os si is s M Mi is ss se ed d   d di ia ag gn no os si is s    O Ov ve er ra al ll l
n n ( (% %) ) P Pr re eg gn na an nc cy y    n n ( (% %) ) P Pr re eg gn na an nc cy y n n ( (% %) ) P Pr re eg gn na an nc cy y
c co om mp pl li ic ca at ti io on n, ,   n n ( (% %) ) c co om mp pl li ic ca at ti io on n, ,   n n ( (% %) ) c co om mp pl li ic ca at ti io on n, ,   n n ( (% %) )
1st trimester 458 134 (29.3) 13 (9.7) 8 (1.7) 2 (25.0) 142 (31.0) 15 (10.6)
2nd trimester 449 69 (15.4) 4 (5.8) 13 (2.9) 6 (46.2) 82 (18.3) 10 (12.2)
3rd trimester 837 49 (5.9) 6 (12.2) 2 (0.2) 0 51 (6.1) 6 (11.8)
Total 1744 252 (14.4) 23 (9.1) 23 (1.3) 8 (34.8) 275 (15.8) 31 (11.3)
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of thyroid function tests in non-pregnant individuals
is smaller than the inter-individual variation. In our
study, we established respectively two different series
of  reference  intervals  during  pregnancy:  self-
sequential longitudinal reference intervals (SLRI) and
general gestation-specific reference intervals (GSRI).
Our  study  showed  that  both  of  them  differed
substantially from that for non-pregnant women.
There  were  no  significant  differences  in  most
reference intervals between SLRI and GSRI. But the
IQR of SLRI was usually smaller than GSRI, especially
in the 1st trimester. So we considered that intra-
individual  variations  of  thyroid  hormones  were
smaller than inter-individual variations also during
pregnancy. Boas et al. [28] also drew a similar
conclusion. The SLRI could reduce the variation
caused by sampling error from different groups and
reflected the changes of thyroid function in pregnant
women  more  realistically,  resulting  in  a more
important value for clinical diagnosis and therapy.
More and more researchers are aware of the
importance of evaluating maternal thyroid function
during pregnancy by gestation-specific reference
intervals. If a non-pregnant reference interval is
used, a number of maternal thyroid diseases could
be potentially misclassified. Stricker et al. [14] have
reported that 5.6-18.3% of misdiagnoses and missed
diagnoses likely occur in clinical practice due to the
use  of  the  non-pregnant  normal  population
reference  values  as  a basis  for  diagnosis.  The
potential for misclassification was greatest in the
first trimester (10.4%) for TSH [14]. In China, the
percentage of potentially misclassified cases of
subclinical hypothyroidism and hypothyroxinaemia
in pregnant women was decreased by using the
gestational age-specific reference intervals [15].
Similar results were obtained in Malaysia [16] and
Australia [21]. As a single hormone determination,
serum TSH provides the most sensitive index to
reliably detect thyroid function abnormalities [26].
So we explored the clinical value of TSH of SLRI at
first. We investigated the status of thyroid hormone
by screening 1744 pregnant women with three kinds
of reference intervals: SLRI, GSRI and non-pregnant
reference intervals. After comparing the results and
pregnancy outcome, we found that SLRI had the
best clinical specificity among the three reference
intervals. Women whose TSH level was outside SLRI
would have higher risk of pregnancy complications,
especially in the 1st trimester and 2nd trimester.
Applying the non-pregnant reference intervals to
pregnant women results in misclas  sification of
thyroid status for 6.1-31.0% of women. Use of non-
pregnant reference intervals has the potential to
result in a large number of misclassified results. The
SLRI can be used to decrease the percen  tage of
potential misclassification of thyroid dysfunction.
Thyroid disorders are common in pregnancy and
affect  maternal  and  fetal  outcome.  Our  data
showed that 0.11-3.90% of women would have got
thyroid  diseases  during  pregnancy.  Subclinical
hypothyroidism is the most common maternal
thyroid disorder. Some studies have reported that
thyroid  insufficiency  may  be  associated  with
adverse obstetric outcome and fetal neurodeve  -
lopmental deficits [1, 29]. So it is important to find
thyroid hormone deficiency during the early stage
of pregnancy. At the same time, TPO-Ab is used to
predict some autoimmune thyroid diseases, such
as post-partum thyroiditis [30]. Higher TPO-Ab level
during pregnancy is also a marker of the danger of
the development of postpartum thyroiditis [31];
about 50% of TPO-Ab positive women will get
thyroid dysfunction after delivery [30-32]. In the
present study, TPO-Ab was detectable in 8.66% of
pregnant women. Evaluating the TPO-Ab levels may
be helpful in later pregnancy. Overall, we think
screening  for  thyroid  dysfunction  of  pregnant
women is recommended and important. 
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